6UJV | pdb_00006ujv

Model of the HIV-1 gp41 membrane-proximal external region, transmembrane domain and cytoplasmic tail (LLP2)


SOLUTION NMR
NMR Experiment
ExperimentTypeSample ContentsSolventIonic StrengthpHPressureTemperature (K)Spectrometer
12D 1H-15N TROSY-HSQC0.7 mM [U-13C; U-15N; U-85% 2H] HIV-1 gp41 TMD-CT(LLP2), 40 mM MES, 40 mM DMPC, 80 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III HD 600
23D TROSY HNCO0.7 mM [U-13C; U-15N; U-85% 2H] HIV-1 gp41 TMD-CT(LLP2), 40 mM MES, 40 mM DMPC, 80 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III HD 600
33D TROSY HNCA0.7 mM [U-13C; U-15N; U-85% 2H] HIV-1 gp41 TMD-CT(LLP2), 40 mM MES, 40 mM DMPC, 80 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III HD 600
42D 1H-15N TROSY-HSQC0.7 mM [U-13C; U-15N; U-85% 2H] HIV-1 gp41 TMD-CT(LLP2), 40 mM MES, 40 mM DMPC, 80 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 750
53D TROSY HN(CA)CO0.7 mM [U-13C; U-15N; U-85% 2H] HIV-1 gp41 TMD-CT(LLP2), 40 mM MES, 40 mM DMPC, 80 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 750
63D TROSY HN(CO)CA0.7 mM [U-13C; U-15N; U-85% 2H] HIV-1 gp41 TMD-CT(LLP2), 40 mM MES, 40 mM DMPC, 80 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 750
73D TROSY HNCACB0.7 mM [U-13C; U-15N; U-85% 2H] HIV-1 gp41 TMD-CT(LLP2), 40 mM MES, 40 mM DMPC, 80 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 750
82D 1H-15N TROSY-HSQC0.8 mM [U-15N; U-2H] HIV-1 gp41 TMD-CT(LLP2), 40 mM MES, 80 mM DMPC, 80 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 750
93D 15N-edited NOESY-TROSY-HSQC0.8 mM [U-15N; U-2H] HIV-1 gp41 TMD-CT(LLP2), 40 mM MES, 80 mM DMPC, 80 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 750
102D 1H-15N TROSY-HSQC1.0 mM [U-13C; U-15N] HIV-1 gp41 TMD-CT(LLP2), 40 mM MES, 80 mM DMPC, 80 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 800
112D 1H-13C HSQC1.0 mM [U-13C; U-15N] HIV-1 gp41 TMD-CT(LLP2), 40 mM MES, 80 mM DMPC, 80 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 800
123D 15N-edited NOESY-TROSY-HSQC1.0 mM [U-13C; U-15N] HIV-1 gp41 TMD-CT(LLP2), 40 mM MES, 80 mM DMPC, 80 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 800
133D 13C-edited NOESY1.0 mM [U-13C; U-15N] HIV-1 gp41 TMD-CT(LLP2), 40 mM MES, 80 mM DMPC, 80 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 800
142D 1H-15N TROSY-HSQC0.5 mM [U-15N; U-2H] HIV-1 gp41 TMD-CT(LLP2), 40 mM MES, 40 mM DMPC, 80 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 900
153D 15N-edited NOESY-TROSY-HSQC0.5 mM [U-15N; U-2H] HIV-1 gp41 TMD-CT(LLP2), 40 mM MES, 40 mM DMPC, 80 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 900
162D 1H-15N TROSY-HSQC0.5 mM [U-15N; U-2H] HIV-1 gp41 TMD-CT(LLP2), 0.5 mM [U-13C] HIV-1 gp41 TMD-CT(LLP2), 40 mM MES, 40 mM DMPC, 80 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 900
172D 1H-13C HSQC0.5 mM [U-15N; U-2H] HIV-1 gp41 TMD-CT(LLP2), 0.5 mM [U-13C] HIV-1 gp41 TMD-CT(LLP2), 40 mM MES, 40 mM DMPC, 80 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 900
183D 15N-edited NOESY-TROSY-HSQC0.5 mM [U-15N; U-2H] HIV-1 gp41 TMD-CT(LLP2), 0.5 mM [U-13C] HIV-1 gp41 TMD-CT(LLP2), 40 mM MES, 40 mM DMPC, 80 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 900
192D 1H-15N TROSY-HSQC0.5 mM [U-15N; U-2H] HIV-1 gp41 TMD-CT(LLP2), 0.5 mM [U-13C] HIV-1 gp41 TMD-CT(LLP2), 40 mM MES, 40 mM DMPC, 80 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 800
202D 1H-13C HSQC0.5 mM [U-15N; U-2H] HIV-1 gp41 TMD-CT(LLP2), 0.5 mM [U-13C] HIV-1 gp41 TMD-CT(LLP2), 40 mM MES, 40 mM DMPC, 80 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 800
213D J(CH)-modulated NOESY0.5 mM [U-15N; U-2H] HIV-1 gp41 TMD-CT(LLP2), 0.5 mM [U-13C] HIV-1 gp41 TMD-CT(LLP2), 40 mM MES, 40 mM DMPC, 80 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 800
222D 1H-15N TROSY-HSQC0.5 mM [U-15N; U-85% 2H] HIV-1 gp41 TMD-CT(LLP2), 40 mM MES, 40 mM DMPC, 80 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III HD 600
232D 1H-15N TROSY-HSQC0.8 mM [U-13C; U-15N; U-85% 2H] HIV-1 gp41 MPER-TMD, 40 mM MOPS, 50 mM DMPC, 100 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III HD 600
243D TROSY HNCO0.8 mM [U-13C; U-15N; U-85% 2H] HIV-1 gp41 MPER-TMD, 40 mM MOPS, 50 mM DMPC, 100 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III HD 600
253D TROSY HNCA0.8 mM [U-13C; U-15N; U-85% 2H] HIV-1 gp41 MPER-TMD, 40 mM MOPS, 50 mM DMPC, 100 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III HD 600
263D TROSY HN(CA)CO0.8 mM [U-13C; U-15N; U-85% 2H] HIV-1 gp41 MPER-TMD, 40 mM MOPS, 50 mM DMPC, 100 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III HD 600
273D TROSY HN(CO)CA0.8 mM [U-13C; U-15N; U-85% 2H] HIV-1 gp41 MPER-TMD, 40 mM MOPS, 50 mM DMPC, 100 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III HD 600
282D 1H-15N TROSY-HSQC0.8 mM [U-15N; U-2H] HIV-1 gp41 MPER-TMD, 40 mM MOPS, 50 mM DMPC, 100 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 750
293D 15N-edited NOESY-TROSY-HSQC0.8 mM [U-15N; U-2H] HIV-1 gp41 MPER-TMD, 40 mM MOPS, 50 mM DMPC, 100 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 750
302D 1H-15N TROSY-HSQC0.8 mM [U-13C; U-15N] HIV-1 gp41 MPER-TMD, 40 mM MOPS, 50 mM DMPC, 100 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 900
312D 1H-13C HSQC0.8 mM [U-13C; U-15N] HIV-1 gp41 MPER-TMD, 40 mM MOPS, 50 mM DMPC, 100 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 900
323D 15N-edited NOESY-TROSY-HSQC0.8 mM [U-13C; U-15N] HIV-1 gp41 MPER-TMD, 40 mM MOPS, 50 mM DMPC, 100 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 900
333D 13C-edited NOESY0.8 mM [U-13C; U-15N] HIV-1 gp41 MPER-TMD, 40 mM MOPS, 50 mM DMPC, 100 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 900
342D 1H-15N TROSY-HSQC0.4 mM [U-15N; U-2H] HIV-1 gp41 MPER-TMD, 40 mM MOPS, 50 mM DMPC, 100 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 900
353D 15N-edited NOESY-TROSY-HSQC0.4 mM [U-15N; U-2H] HIV-1 gp41 MPER-TMD, 40 mM MOPS, 50 mM DMPC, 100 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 900
362D 1H-15N TROSY-HSQC0.4 mM [U-15N; U-2H] HIV-1 gp41 MPER-TMD, 0.4 mM [U-13C] HIV-1 gp41 MPER-TMD, 40 mM MOPS, 50 mM DMPC, 100 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 900
372D 1H-13C HSQC0.4 mM [U-15N; U-2H] HIV-1 gp41 MPER-TMD, 0.4 mM [U-13C] HIV-1 gp41 MPER-TMD, 40 mM MOPS, 50 mM DMPC, 100 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 900
383D 15N-edited NOESY-TROSY-HSQC0.4 mM [U-15N; U-2H] HIV-1 gp41 MPER-TMD, 0.4 mM [U-13C] HIV-1 gp41 MPER-TMD, 40 mM MOPS, 50 mM DMPC, 100 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 900
392D 1H-15N TROSY-HSQC0.4 mM [U-15N; U-2H] HIV-1 gp41 MPER-TMD, 0.4 mM [U-13C] HIV-1 gp41 MPER-TMD, 40 mM MOPS, 50 mM DMPC, 100 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 800
402D 1H-13C HSQC0.4 mM [U-15N; U-2H] HIV-1 gp41 MPER-TMD, 0.4 mM [U-13C] HIV-1 gp41 MPER-TMD, 40 mM MOPS, 50 mM DMPC, 100 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 800
413D J(CH)-modulated NOESY0.4 mM [U-15N; U-2H] HIV-1 gp41 MPER-TMD, 0.4 mM [U-13C] HIV-1 gp41 MPER-TMD, 40 mM MOPS, 50 mM DMPC, 100 mM DHPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III 800
422D 1H-15N TROSY-HSQC0.8 mM [U-15N; U-85% 2H] HIV-1 gp41 MPER-TMD, 40 mM MOPS, 50 mM DMPC, 85 mM DPC90% H2O/10% D2O0 M6.71 atm308Bruker AVANCE III HD 600
NMR Spectrometer Information
SpectrometerManufacturerModelField Strength
1BrukerAVANCE III HD600
2BrukerAVANCE III750
3BrukerAVANCE III800
4BrukerAVANCE III900
NMR Refinement
MethodDetailsSoftware
simulated annealingX-PLOR NIH
NMR Ensemble Information
Conformer Selection Criteriastructures with the lowest energy
Conformers Calculated Total Number150
Conformers Submitted Total Number15
Representative Model1 (lowest energy)
Computation: NMR Software
#ClassificationVersionSoftware NameAuthor
1collectionTopSpinBruker Biospin
2processingNMRPipeDelaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3peak pickingCARAKeller and Wuthrich
4peak pickingXEASYBartels et al.
5chemical shift assignmentCARAKeller and Wuthrich
6chemical shift assignmentXEASYBartels et al.
7structure calculationX-PLOR NIHSchwieters, Kuszewski, Tjandra and Clore
8refinementX-PLOR NIHSchwieters, Kuszewski, Tjandra and Clore